DK1119359T3 - 2-methyl-thieno-benzodiazepinformulering - Google Patents

2-methyl-thieno-benzodiazepinformulering

Info

Publication number
DK1119359T3
DK1119359T3 DK99915009T DK99915009T DK1119359T3 DK 1119359 T3 DK1119359 T3 DK 1119359T3 DK 99915009 T DK99915009 T DK 99915009T DK 99915009 T DK99915009 T DK 99915009T DK 1119359 T3 DK1119359 T3 DK 1119359T3
Authority
DK
Denmark
Prior art keywords
thieno
methyl
olanzapine
benzodiazepine formulation
formulation
Prior art date
Application number
DK99915009T
Other languages
Danish (da)
English (en)
Inventor
Charles Arthur Bunnell
Thomas Harry Ferguson
Barry Arnold Hendriksen
Manuel Vicente Sanchez-Felix
David Edward Tupper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK1119359T3 publication Critical patent/DK1119359T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99915009T 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepinformulering DK1119359T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation

Publications (1)

Publication Number Publication Date
DK1119359T3 true DK1119359T3 (da) 2004-08-16

Family

ID=26859927

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99915009T DK1119359T3 (da) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepinformulering
DK04005832T DK1468689T3 (da) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK04005832T DK1468689T3 (da) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Country Status (28)

Country Link
EP (1) EP1119359B1 (ja)
JP (1) JP4551988B2 (ja)
CN (1) CN1146422C (ja)
AT (2) ATE359793T1 (ja)
AU (1) AU759751B2 (ja)
BR (1) BR9914156A (ja)
CA (1) CA2344873A1 (ja)
CZ (1) CZ302367B6 (ja)
DE (2) DE69917663T2 (ja)
DK (2) DK1119359T3 (ja)
EA (1) EA002580B1 (ja)
ES (2) ES2285294T3 (ja)
GE (1) GEP20094818B (ja)
HK (1) HK1041199B (ja)
HR (1) HRP20010238B1 (ja)
HU (1) HU227400B1 (ja)
ID (1) ID29574A (ja)
IL (2) IL141766A0 (ja)
MY (1) MY126476A (ja)
NO (1) NO328243B1 (ja)
NZ (1) NZ510208A (ja)
PL (1) PL196821B1 (ja)
PT (2) PT1119359E (ja)
SK (1) SK285944B6 (ja)
TR (1) TR200100885T2 (ja)
TW (1) TW577890B (ja)
UA (1) UA66872C2 (ja)
WO (1) WO2000018408A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1246827B1 (en) * 1999-12-28 2005-04-13 Cipla Limited New polymorphic forms of olanzapine
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
WO2006006185A1 (en) * 2004-07-14 2006-01-19 Shasun Chemicals And Drugs Limited Improved process for making form i of olanzapine.
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
EP2623095A1 (en) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
DK1838716T3 (da) * 2005-01-05 2011-07-25 Lilly Co Eli Olanzapinpamota-dihydrat
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
ES2654147T3 (es) * 2009-11-16 2018-02-12 Ipsen Pharma S.A.S. Composiciones farmacéuticas de ligandos del receptor de melanocortina
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
US9469630B2 (en) 2010-10-18 2016-10-18 Sumitomo Dainippon Pharma Co., Ltd. Sustained-release formulation for injection
WO2014125500A1 (en) 2013-02-13 2014-08-21 Neuland Laboratories Limited A process for preparation of olanzapine pamoate
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
WO2018172850A1 (en) * 2017-03-20 2018-09-27 Teva Pharmaceuticals International Gmbh Sustained release olanzapine formulaitons

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA933134B (en) * 1992-05-08 1993-11-30 Akzo Nv Depot preparation
WO1994010982A1 (en) * 1992-11-17 1994-05-26 Yoshitomi Pharmaceutical Industries, Ltd. Sustained-release microsphere containing antipsychotic and process for producing the same
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
NZ334346A (en) * 1996-09-23 2000-05-26 Lilly Co Eli Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders
BR9813228A (pt) * 1997-09-30 2000-08-29 Lilly Co Eli Formulação de 2-metil-tieno-benzodiazepina

Also Published As

Publication number Publication date
HUP0103636A2 (hu) 2002-01-28
UA66872C2 (uk) 2004-06-15
TW577890B (en) 2004-03-01
EP1119359A4 (en) 2001-12-19
PT1119359E (pt) 2004-08-31
TR200100885T2 (tr) 2001-08-21
JP2002525330A (ja) 2002-08-13
DE69917663T2 (de) 2005-05-25
AU3362799A (en) 2000-04-17
AU759751B2 (en) 2003-05-01
ES2221376T3 (es) 2004-12-16
HK1041199B (zh) 2005-03-18
PL346981A1 (en) 2002-03-11
NO20011583L (no) 2001-03-28
EP1119359B1 (en) 2004-05-26
SK4162001A3 (en) 2002-03-05
CN1146422C (zh) 2004-04-21
DE69935873T2 (de) 2008-01-10
CZ20011149A3 (cs) 2002-01-16
DE69935873D1 (de) 2007-05-31
PT1468689E (pt) 2007-07-09
EA200100406A1 (ru) 2001-10-22
EP1119359A1 (en) 2001-08-01
ATE267602T1 (de) 2004-06-15
ES2285294T3 (es) 2007-11-16
MY126476A (en) 2006-10-31
CA2344873A1 (en) 2000-04-06
HRP20010238B1 (en) 2006-05-31
DK1468689T3 (da) 2007-08-13
CN1320038A (zh) 2001-10-31
SK285944B6 (sk) 2007-11-02
BR9914156A (pt) 2001-06-26
DE69917663D1 (de) 2004-07-01
HU227400B1 (en) 2011-05-30
HK1041199A1 (en) 2002-07-05
WO2000018408A1 (en) 2000-04-06
GEP20094818B (en) 2009-11-10
HRP20010238A2 (en) 2002-04-30
JP4551988B2 (ja) 2010-09-29
IL141766A (en) 2006-12-31
CZ302367B6 (cs) 2011-04-13
ATE359793T1 (de) 2007-05-15
NO328243B1 (no) 2010-01-11
EA002580B1 (ru) 2002-06-27
HUP0103636A3 (en) 2003-05-28
NO20011583D0 (no) 2001-03-28
IL141766A0 (en) 2002-03-10
ID29574A (id) 2001-09-06
PL196821B1 (pl) 2008-02-29
NZ510208A (en) 2003-04-29

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
ATE267602T1 (de) 2-methyl-thieno-benzodiazepin-formulierung
NO20010556L (no) Fremgangsmate for oftalmisk administrering
YU15499A (sh) Olanzapin dihidrat d
EA199900373A2 (ru) Фармацевтические композиции
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
RS49688B (sr) Novi derivat 3-aril-2- hidroksipropionske kiseline (i)
YU15299A (sh) Farmaceutski sastavi
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
IT1307928B1 (it) Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
NL1006065A1 (nl) Inlegkruisje voor stringslip.
DK1073447T3 (da) N1-modificerede glycopeptider
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
IT1287349B1 (it) Pertica per il livellamento di superfici intonacate.
IT1287307B1 (it) Pertica per il livellamento di superfici intonacate.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
JO2087B1 (en) Pharmacy combinations